留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

中医药转化医学研究现状与发展述评

程海波 沈卫星 吴勉华 孙东东

程海波, 沈卫星, 吴勉华, 孙东东. 中医药转化医学研究现状与发展述评[J]. 南京中医药大学学报, 2016, 32(5): 401-404.
引用本文: 程海波, 沈卫星, 吴勉华, 孙东东. 中医药转化医学研究现状与发展述评[J]. 南京中医药大学学报, 2016, 32(5): 401-404.
CHENGHai-bo, SHENWei-xing, WUMian-hua, SUNDong-dong. Research Status and Development Review of Translational Medicine of Traditional Chinese Medicine[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(5): 401-404.
Citation: CHENGHai-bo, SHENWei-xing, WUMian-hua, SUNDong-dong. Research Status and Development Review of Translational Medicine of Traditional Chinese Medicine[J]. Journal of Nanjing University of traditional Chinese Medicine, 2016, 32(5): 401-404.

中医药转化医学研究现状与发展述评

Research Status and Development Review of Translational Medicine of Traditional Chinese Medicine

  • 摘要: 转化医学作为一种全新的医学理念及实践模式,代表的是当今医学科学发展的重要趋势和必然要求,其倡导基础研究与临床应用之间的双向快速转化。就中医药学与转化医学的相互关系,中药复方在中医药转化医学研究中的作用进行阐述,并围绕如何服务临床转化,提出中药复方基础研究的思路与策略的重点在于中医理论的创新、临床有效药物的开发、疾病防治新机制的发现、复方配伍的机理和规律的阐明。

     

  • [1] CHOI DW. Bench to bedside: the glutamate connection[J]. Science, 1992,258(5080):241-243.
    [2] GERAGHTY J. Adenomatous polyposis coli and translational medicine[J]. Lancet, 1996,348(9025):422.
    [3] ZERHOUNI E. The NIH Roadmap[J]. Science, 2003,302(5642):63-72.
    [4] SARKAR IN. Biomedical informatics and translational medicine[J]. J Transl Med, 2010, 8:22.
    [5] LITTMAN BH, MARIO LD, PLEBANI M, et al. What's next in translational medicine[J]. Clin Sci, 2007,112(4):217-227.
    [6] 董尔丹,胡海,洪微.浅析转化医学与医学实践[J].科学通报,2013,58(1):53-62.
    [7] DONG ED, HU H, HONG W. Exploration on translational medicine and medical practice[J]. Sci Bul, 2013, 58(1): 53-62.
    [8] 肖小河,王伽伯,鄢丹,等.转化医学:让中药现代化又快又好走进临床[J].中草药, 2012,43(1):1-8.
    [9] XIAO XH, WANG JB, YAN D, et al. Translational medicine: a better and faster way for modernization of Chinese materia medica to enter clinic[J]. Chin Tradit Herbal Drugs, 2012, 43(1): 1-8.
    [10] 陈丹霞,汪楠,安佳璐,等.国外转化医学研究发展经验与启示[J].医学分子生物学杂志,2012,9(5):384-387.
    [11] CHEN DX, WANG N, AN JL, et al. Experience and enlightenment from overseas development of translational medicine[J]. J Med Mol Biol, 2012, 9(5): 384-387.
    [12] 吴以岭,袁国强,贾振华,等.脉络学说的学术地位及其应用价值[J].中医杂志, 2012,53(1): 3-7.
    [13] WU YL, YUAN GQ, JIA ZH, et al. Academic position of vessels networks theory and its application[J]. J Tradit Chin Med, 2012, 53(1): 3-7.
    [14] 张洪春,赵丹,晁燕,等.从苏黄止咳胶囊的研发探讨中药新药选题思路[J].中药新药与临床药理,2009,20(5):485-487.
    [15] ZHANG HC, ZHAO D, CHAO Y, et al. Thoughts on topic selection of new Chinese herbs from the research and development of Suhuang Zhike Capsule[J]. Tradit Chin Drug Res Clin Pharmacol, 2009, 20(5): 485-487.
    [16] 程海波,沈卫星,姚志华,等.基于癌毒病机理论的消癌解毒方抗肿瘤研究进展[J].南京中医药大学学报(自然科学版), 2014,30(6):593-595.
    [17] CHENG HB, SHEN WX, YAO ZH, et al. Research process of Xiaoai Jiedu Formula from its pathogenesis of cancerous toxin[J]. J Nanjing Univ Tradit Chin Med, 2014, 30(6): 593-395.
    [18] 程海波,沈卫星.癌毒病机理论与炎癌转变[J].中国中西医结合杂志,2015,35(2):243-246.
    [19] CHENG HB, SHEN WX. Pathogenesis theory of cancerous toxin and transformation between inflammation to carcinoma[J]. Chin J Integr Tradit West Med, 2015, 35(2): 243-246.
    [20] 沈政洁,程海波,沈卫星,等.肿瘤炎性微环境与“癌毒”病机相关性探讨[J].北京中医药大学学报,2015, 38(1):14-17.
    [21] SHEN ZJ, CHENG HB, SHEN WX, et al. Correlation between tumor inflammatory micro environment and cancerous toxin pathogenesis[J]. J Beijing Univ Tradit Chin Med, 2015, 38(1): 14-17.
    [22] 程海波,吴勉华,沈卫星,等.基于癌毒病机理论的癌痛平胶囊治疗癌性疼痛的研究[J].中华中医药杂志,2015,30(12):4371-4374.
    [23] CHENG HB, WU MH, SHEN WX, et al. Study of Aitongping Capsule on treating cancerous pain based on the pathogenesis theory of cancerous toxin[J]. Chin J Tradit Chin Med Pharm, 2015, 30(12): 4371-4374.
    [24] 程海波.癌毒病机理论探讨[J].中医杂志,2014,55(20):1711-1714.
    [25] CHENG HB. Discussion on the pathogenesis theory of cancer toxin[J]. J Tradit Chin Med, 2014, 55(20): 1711-1714.
    [26] CONTOPOULOS-LOANNIDIS DG, NTZANI E, LOANNIDIS JP. Translation of highly promising basic science research into clinical applications[J]. Am J Med, 2003,114(6):477-484.
    [27] LEHMANN CU, ALTUWAIJRI MM, LI YC, et al. Translational research in medical informatics or from theory to practice. A call for an applied informatics journal[J]. Methods Inf Med, 2008,47(1):1-3.
    [28] BUTLER D. Translational research: crossing the valley of death[J]. Nature, 2008, 453(42):840-842.
    [29] 王阶,郭丽丽,杨戈,等.方剂配伍理论研究方法及研究前景[J].世界科学技术-中医药现代化,2006, 8(1):1-5.
    [30] WANG J, GUO LL, YANG G, et al. Research method and prospect on compatibility theory of formula[J]. Mod Tradit Chin Med Mater Med-World Sci Technol, 2006, 8(1):1-5.
    [31] 王喜军,张伯礼.基于药物代谢组学的方剂配伍规律及配伍科学价值揭示.中国中药杂志,2010, 35(10):1346-1348.
    [32] WANG XJ, ZHANG BL. Elucidation of compatibility principle and scientific value of Chinese medical formula based on pharmacometabolomics[J]. China J Chin Mater Med, 2010, 35(10): 1346-1348.
  • 加载中
计量
  • 文章访问数:  981
  • HTML全文浏览量:  5
  • PDF下载量:  612
  • 被引次数: 0
出版历程
  • 收稿日期:  2016-04-03
  • 修回日期:  2016-07-28
  • 刊出日期:  2016-09-10

目录

    /

    返回文章
    返回